Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib
{{output}}
The incidence of the ROS1 fusion mutation (ROS proto-oncogene 1) in non-small cell lung cancer (NSCLC) is approximately 1-2%. At least 55 partner genes have been identified that can fuse with ROS1.Herein, we report a case of a lung adenocarcinoma patient harbo... ...
